psma adc in prostate cancer: phase i results
Published 5 years ago • 146 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
2:25
phase i trial of arx517, an anti-psma adc, in mcrpc
-
0:50
psma adc for prostate cancer
-
1:30
vbir vaccine shows promise in prostate cancer: phase i trial results and immunotherapy potential
-
2:19
what are the latest in adcs for prostate and bladder cancer?
-
3:50
the role of psma pet in recurrent prostate cancer
-
8:23
results from a phase i study of amg 160
-
3:30
radionuclide conjugates 225ac-j591 and 177lu-psma-i&t for mcrpc
-
2:55
dr. nicholas vogelzang discusses psma adc in prostate cancer
-
5:47
phase i/ii dose-escalation study of 225ac-j591 in progressive mcrpc
-
2:05
what role will adcs play in the prostate cancer treatment landscape?
-
5:37
177lu-psma-617 for the early treatment of prostate cancer
-
6:45
177lu-psma-617 for prostate cancer: therap, vision, upfrontpsma and lutectomy
-
1:05
dr. petrylak on psma adc for patients with mcrpc
-
1:17
prince: 177lu-psma-617 and pembrolizumab in prostate cancer
-
0:25
psma pet scans for prostate cancer
-
1:20
updates in psma radiopharmaceutical therapies for prostate cancer
-
1:23
dr. petrylak on a phase ii trial of psma adc in taxane-treated mcrpc
-
1:36
advances in psma-targeted therapy for prostate cancer
-
17:05
psma targeting for treatment of advanced prostate cancer - 2021 prostate cancer patient conference